EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis

Inbar Yacoby-Halevi, Boris Kruchin, Chen Gadot, Dmitri Guz, Assaf Rotmensh, Yonatan Shaleve, Hila Sharon, Noam Greenberg, Boris Fishman, Edward Itelman, Aviad Rotholz, Keren Skalsky und 5 weitere

Cardiology · 09.06.2026 · 1-9

DOI: 10.1159/000552641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology, online erschienen am 09.06.2026. Verfasst von Inbar Yacoby-Halevi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, inbaryacoby@mail.tau.ac.il. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ticagrelor is a widely used potent P2Y12 inhibitor in patients aged ≥75 years with acute coronary syndromes. Despite its widespread use, data on ticagrelor’s safety in older adults remain limited.

Methods

We performed a retrospective pharmacovigilance analysis using the FDA Adverse Event Reporting System from 2010 to 2024. Disproportionality analysis compared ticagrelor with clopidogrel, assessing predefined adverse events in adults (

Schlagwörter

Stichwörter der Autor:innen

Acute coronary syndromeAdverse effectAnti-plateletsElderly patientsTicagrelor

Autor:innen und Institutionen

  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel, inbaryacoby@mail.tau.ac.il.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
  • Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Division of Cardiology, Department of Medicine, Columbia University, New York, New York, USA.

Zitieren

APA

Yacoby-Halevi, I., Kruchin, B., Gadot, C., Guz, D., Rotmensh, A., Shaleve, Y., Sharon, H., Greenberg, N., Fishman, B., Itelman, E., Rotholz, A., Skalsky, K., Orvin, K., Eisen, A., Kornowski, R., Lerman, T. T., & Levi, A. (2026). The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis. Cardiology, 1-9. https://doi.org/10.1159/000552641

Vancouver

Yacoby-Halevi I, Kruchin B, Gadot C, Guz D, Rotmensh A, Shaleve Y, et al. The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis. Cardiology. 2026:1-9. doi:10.1159/000552641

BibTeX
@article{YacobyHalevi2026,
  author = {Yacoby-Halevi, Inbar and Kruchin, Boris and Gadot, Chen and Guz, Dmitri and Rotmensh, Assaf and Shaleve, Yonatan and Sharon, Hila and Greenberg, Noam and Fishman, Boris and Itelman, Edward and Rotholz, Aviad and Skalsky, Keren and Orvin, Katia and Eisen, Alon and Kornowski, Ran and Lerman, Tsahi T and Levi, Amos},
  title = {The Safety Profile of Ticagrelor among Older Adults (Age ≥75 years): A Pharmacovigilance Analysis},
  journal = {Cardiology},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000552641}
}
Kostenlos starten →